The Investment Objective of the Ecclesiastical International Growth Fund is to achieve long-term capital growth with a reasonable level of income.
Name | % Net Assets |
---|---|
Lonking Holdings | 2.9% |
Telefonica S.A. ADS | 2.4% |
Roche Holding AG Part. Cert. | 2.4% |
StatoilHydro ASA | 2.3% |
China Shineway Pharmaceutical Group | 2.3% |
Sanofi-Aventis S.A. | 2.1% |
Scud Group | 2.1% |
GlaxoSmithKline | 2.0% |
Swatch Group AG | 1.9% |
Novartis | 1.7% |
Key | % Net Assets |
---|---|
Lonking Holdings | 2.9% |
Telefonica S.A. ADS | 2.4% |
Roche Holding AG Part. Cert. | 2.4% |
StatoilHydro ASA | 2.3% |
Other | 90% |
Date | 21-Nov-2024 |
---|---|
NAV | 434.90p |
Currency | GBP |
Change | -0.90p |
% | -0.21% |
YTD change | 23.10p |
YTD % | 5.61% |
Fund Inception | 13/09/1999 |
---|---|
Fund Manager | Robin Hepworth |
TER | - |
Minimum Investment | |
---|---|
Initial | £1000000 |
Additional | n/a |
Savings | £25 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.15 |
You are here: research